Explore more publications!

Palau Science & Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palau Science & Technology Journal.

Press releases published on November 13, 2025

Fennec Pharmaceuticals Announces Proposed Offering of Common Shares
nCino Announces Timing of its Third Quarter Fiscal Year 2026 Financial Results Conference Call 
Maris-Tech Enters Quantum Navigation Field with Strategic Agreement to Develop Quantum-Based Gyroscope to Replace GPS Navigation
Astera Labs Announces Fourth Quarter 2025 Financial Conference Participation
Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Intchains Group Limited Reports Third Quarter and Nine Months 2025 Financial Results
Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis
BioSyent Schedules Q3 and YTD 2025 Earnings Release for November 20, 2025
BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results
ORIC® Pharmaceuticals Announces Completion of Dose Exploration Portion of ORIC-944 Phase 1b Clinical Trial and Continues to Demonstrate Potential Best-in-Class Efficacy and Safety
Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update
zSpace Reports Third Quarter 2025 Financial Results
PacBio to Present at Upcoming Investor Conferences
Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Aterian Reports 2025 Third Quarter Financial Results and Reiterates Guidance
AirJoule Technologies (NASDAQ: AIRJ) Announces Third Quarter 2025 Results and Provides Business Update
RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions